Intrinsic Value of S&P & Nasdaq Contact Us

Spruce Biosciences, Inc. SPRB NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
51/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$234.00
+232.4%

Stock Statistics — SPRB

Spruce Biosciences, Inc. (SPRB) has a market capitalization of $96.58M and trades at $70.39. The 52-week range is 7-1777.5.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.4, Earnings Per Share (EPS) of $-50.83.

The stock has a beta of 3.68, operates in the Healthcare sector.

Trading Data
Current Price$70.39
52-Week Range7-1777.5
Volume51.27K
Avg Volume (30D)45.48K
Market Cap$96.58M
Beta (1Y)3.68
Company
IPO Date2020-10-09
Employees20
CEOJavier Szwarcberg
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS85209E2081
CUSIP85209E208
Income (Latest Year)
Gross Profit$-21K
EBITDA$-36.51M
Operating Income$-36.51M
Net Income$-38.97M
EPS$-50.83
EPS Diluted$-50.83
Shares Outstanding$766.6K
Balance Sheet (Latest Year)
Total Assets$53.02M
Current Assets$52.11M
Cash & ST Investments$48.91M
Total Liabilities$10.51M
Total Debt$736K
Net Debt$-48.17M
Total Equity$42.52M
Debt / Equity0.02
Valuation Ratios
P/E Ratio-1.4
P/B Ratio2.27
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message